tiprankstipranks
Trending News
More News >
Owlet (OWLT)
NYSE:OWLT
US Market

Owlet (OWLT) AI Stock Analysis

Compare
91 Followers

Top Page

OW

Owlet

(NYSE:OWLT)

Rating:57Neutral
Price Target:
$7.00
▲(1.30%Upside)
Owlet's overall stock score is primarily influenced by its significant financial challenges, which are partially offset by positive earnings call outcomes and technical indicators. The company's efforts to enhance financial flexibility and international expansion are promising, but the negative P/E ratio and cash flow challenges remain critical concerns.
Positive Factors
Financial performance
OWLT delivered a strong first quarter, beating revenue and adjusted EBITDA estimates.
Market position
Owlet dominates the smart baby monitor segment, being the first and only FDA-cleared smart baby monitors presently on the market.
Partnerships
OWLT announced a new partnership with the Children's Hospital of The King's Daughter, allowing babies to leave the hospital with an OWLT monitor.
Negative Factors
Financial guidance
Management lowered the gross margin guide due to tariff concerns.
Market attention
Owlet has been overlooked by investors, but it deserves attention and has been initiated with a Buy rating.

Owlet (OWLT) vs. SPDR S&P 500 ETF (SPY)

Owlet Business Overview & Revenue Model

Company DescriptionOwlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.
How the Company Makes MoneyOwlet generates revenue primarily through the sale of its smart baby monitoring devices and related accessories. The company sells its products directly to consumers via its e-commerce platform and through various retail partners, both online and in physical stores. Additionally, Owlet may offer subscription services for enhanced features or additional functionalities of its products, which can provide a recurring revenue stream. Key partnerships with retailers and potential collaborations with healthcare providers can significantly contribute to its earnings by expanding its market reach and enhancing product distribution. Owlet's focus on continuous innovation and product development also plays a crucial role in maintaining and growing its customer base, thereby driving revenue growth.

Owlet Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 65.71%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The earnings call conveyed a positive sentiment, with strong revenue growth, improved margins, successful product adoption, and strategic partnerships outweighing challenges from tariffs and litigation costs.
Q1-2025 Updates
Positive Updates
Revenue Growth
Revenue for Q1 2025 was $21.1 million, marking a 43% increase year-over-year, driven by strong sales of Dream Sock and Dream Duo.
Gross Margin Improvement
The gross margin improved by 930 basis points year-over-year to 53.7%, marking the eighth consecutive quarter of gross margin expansion.
Owlet 360 Subscription Success
Owlet 360 has over 48,000 paying subscribers since its launch on January 28th, indicating strong adoption and contributing positively to the business.
Strategic Partnerships
A new distribution partnership with Children’s Hospital of the King’s Daughters allows babies to leave the hospital with an Owlet monitor, marking a significant milestone.
International Expansion
International revenue grew by 104% year-over-year, with significant growth in France and Germany.
Financial Performance
Owlet achieved breakeven adjusted EBITDA for the fourth consecutive quarter, with a $3.1 million improvement year-over-year.
Negative Updates
Tariff Challenges
Newly implemented 10% tariffs on imports from Thailand and Vietnam impact gross margin expectations, though the company has eliminated material exposure to China tariffs.
Litigation Settlement Costs
Operating expenses increased due to $0.9 million one-time litigation settlement costs related to a shareholder derivative suit.
Company Guidance
During the Owlet Q1 2025 Earnings Conference Call, the company reported robust financial performance, surpassing expectations with a 43% year-over-year revenue growth, amounting to $21.1 million. This growth was driven by strong sales of their Dream Sock and Dream Duo products, as well as early success with their Owlet 360 subscription service, which had over 48,000 paying subscribers. The company achieved a gross margin of 53.7%, marking their eighth consecutive quarter of year-over-year gross margin expansion. Despite a challenging macroeconomic environment, Owlet maintained breakeven adjusted EBITDA for the fourth consecutive quarter, improving by $3.1 million year-over-year. As a result of the strong start to the year, Owlet raised its full-year revenue guidance to between $91 million and $95 million, anticipating 17% to 22% growth. The company also highlighted strategic partnerships, including a new distribution agreement with Children’s Hospital of the King’s Daughters, and continued international expansion with revenue growth of 104% year-over-year in international markets.

Owlet Financial Statement Overview

Summary
Owlet faces significant financial challenges with persistent net losses, negative equity, and cash flow issues. While recent revenue growth and improvements in EBITDA provide some optimism, the company must address its high liabilities and negative cash flows to achieve financial stability.
Income Statement
45
Neutral
Owlet's revenue shows inconsistency, with recent growth from 2023 to TTM after a dip. However, persistent negative net income and negative EBIT margins indicate ongoing profitability issues. The company has shown some improvement in EBITDA, suggesting potential for operational efficiency gains.
Balance Sheet
30
Negative
The balance sheet reveals significant challenges, with negative stockholders' equity indicating potential solvency issues. The debt-to-equity ratio calculation is not feasible due to negative equity, but the high total liabilities relative to assets suggest financial instability.
Cash Flow
40
Negative
Free cash flow remains negative, indicating ongoing liquidity challenges. The operating cash flow to net income ratio is negative, highlighting inefficiencies in translating revenue into cash. Despite these challenges, there is a positive trend in financing cash flow, reflecting efforts to bolster liquidity through external funding.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
84.42M78.06M54.01M69.20M75.80M75.40M
Gross Profit
44.12M39.31M22.59M23.30M35.00M35.88M
EBIT
-17.04M-20.22M-28.63M-84.60M-55.70M-6.99M
EBITDA
-10.41M-9.47M-27.49M-75.53M-42.71M-8.25M
Net Income Common Stockholders
-12.79M-12.54M-32.90M-79.29M-98.17M-10.52M
Balance SheetCash, Cash Equivalents and Short-Term Investments
16.31M20.25M16.56M11.20M95.10M17.01M
Total Assets
51.40M49.52M44.12M58.10M140.00M40.12M
Total Debt
10.05M11.70M15.22M16.30M16.50M28.84M
Net Debt
-6.26M-8.55M-1.34M5.10M-78.60M11.83M
Total Liabilities
63.40M66.33M73.80M68.70M84.80M60.94M
Stockholders Equity
13.81M-16.81M-29.68M-10.60M55.20M-20.82M
Cash FlowFree Cash Flow
-14.51M-11.97M-23.59M-82.97M-42.62M-1.19M
Operating Cash Flow
-13.79M-11.21M-23.53M-81.40M-40.60M-129.00K
Investing Cash Flow
-817.00K-761.00K-59.00K-1.60M-2.00M-1.06M
Financing Cash Flow
12.82M16.04M28.91M-900.00K120.60M6.46M

Owlet Technical Analysis

Technical Analysis Sentiment
Positive
Last Price6.91
Price Trends
50DMA
4.71
Positive
100DMA
4.59
Positive
200DMA
4.62
Positive
Market Momentum
MACD
0.57
Negative
RSI
73.64
Negative
STOCH
54.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OWLT, the sentiment is Positive. The current price of 6.91 is above the 20-day moving average (MA) of 5.82, above the 50-day MA of 4.71, and above the 200-day MA of 4.62, indicating a bullish trend. The MACD of 0.57 indicates Negative momentum. The RSI at 73.64 is Negative, neither overbought nor oversold. The STOCH value of 54.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OWLT.

Owlet Risk Analysis

Owlet disclosed 76 risk factors in its most recent earnings report. Owlet reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Owlet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
$105.21M-16.53%-4.15%3.49%
57
Neutral
$110.05M60.56%45.51%49.64%
54
Neutral
$86.73M-26.20%20.81%-498.66%
54
Neutral
$5.34B3.36-45.10%3.39%16.81%-0.03%
51
Neutral
$55.71M-67.86%0.34%6.20%
50
Neutral
$571.24M-29.16%25.77%49.44%
45
Neutral
$76.38M-94.65%-5.86%50.76%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OWLT
Owlet
6.91
2.29
49.57%
ICAD
iCAD
3.77
2.32
160.00%
CTSO
Cytosorbents
1.20
0.45
60.00%
XTNT
Xtant Medical Holdings
0.60
-0.10
-14.29%
BFLY
Butterfly Network
2.20
1.32
150.00%
HYPR
Hyperfine
0.70
-0.13
-15.66%

Owlet Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Owlet Amends Credit Agreement to Boost Flexibility
Positive
Jun 16, 2025

On June 11, 2025, Owlet, Inc. and its subsidiary Owlet Baby Care, Inc. entered into a First Amendment to their Credit and Security Agreement with financial institutions and ABL OPCO LLC. This amendment modifies financial covenants, increases allowable capital expenditures, and expands borrowing eligibility against certain accounts receivable, potentially enhancing the company’s financial flexibility and operational capacity.

The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.